Cell Cycle Checkpoints p16 and p21-Strong Predictors of Clinicopathologic Outcomes in High-Grade Osteosarcoma.

Cell Cycle Checkpoints p16 and p21-Strong Predictors of Clinicopathologic Outcomes in High-Grade Osteosarcoma. Cancer J. 2024 May-Jun 01; 30(3):133-139.

View in: PubMed

subject areas

Adolescent
Adult
Aged
Biomarkers, Tumor
Bone Neoplasms
Cell Cycle Checkpoints
Child
Cyclin-Dependent Kinase Inhibitor p16
Cyclin-Dependent Kinase Inhibitor p21
Female
Humans
Immunohistochemistry
Male
Middle Aged
Neoplasm Grading
Osteosarcoma
Prognosis
Young Adult

authors with profiles

Terrie Vasilopoulos